Skip to main content

Table 7 Cases of adverse reactions that have not been reported for the branded drug

From: A laboratory data-based evaluation of the efficacy and safety of generic pravastatin sodium for long-term use

Adverse reaction Course
Discomfort A 48-year-old man complained of discomfort after receiving Maibastan® for 10 months, and the treatment was discontinued. Before symptom onset, the concomitant drugs had not been changed. Discontinuation of Maibastan® and the concomitant drugs* resulted in symptom relief.
*Bayaspirin®, Juvela®, Foliamin®, Erythrocin®, and Mucodyne®
A 76-year-old man complained of discomfort after receiving Maibastan® for 2 months, and the treatment was discontinued. Before symptom onset, the concomitant drugs* had not been changed. Discontinuation of Maibastan®, Urief®, Tenormin®, and Myslee® resulted in symptom relief.
*Urief®, Tenormin®, Myslee®, Adalat®, and Blopress®
An 88-year-old woman complained of discomfort after receiving Maibastan® for 2 months, and drug treatment was changed to Epadel®. Before symptom onset, the concomitant drugs* had not been changed. Discontinuation of Maibastan® and Hachimi-jio-gan® resulted in symptom relief.
*Thyradin S® and Hachimi-jio-gan®
Arrhythmia A 66-year-old woman complained of the sensation of having a racing pulse after receiving Maibastan® for 20 months, and the treatment was discontinued. Before symptom onset, the concomitant drugs* had not been changed. Discontinuation of Maibastan® resulted in symptom relief.
*Olmetec® and Fastic®